Adipokines as novel biomarkers and regulators of the metabolic syndrome.

Research output: Contribution to journalArticle

292 Citations (Scopus)

Abstract

Over the past two decades our view of adipose tissue has undergone a dramatic change from an inert energy storage tissue to an active endocrine organ. Adipose tissue communicates with other central and peripheral organs by synthesis and secretion of a host of molecules that we generally refer to as adipokines. The levels of some adipokines correlate with specific metabolic states and have the potential to impact directly upon the metabolic homeostasis of the system. A dysregulation of adipokines has been implicated in obesity, type 2 diabetes, hypertension, cardiovascular disease, and an ever-growing larger list of pathological changes in a number of organs. Here, we review the recent progress regarding the synthesis, secretion, and physiological function of adipokines with perspectives on future directions and potential therapeutic goals.

Original languageEnglish (US)
JournalAnnals of the New York Academy of Sciences
Volume1212
StatePublished - Nov 2010

Fingerprint

Adipokines
Biomarkers
Tissue
Adipose Tissue
Medical problems
Energy storage
Type 2 Diabetes Mellitus
Homeostasis
Cardiovascular Diseases
Obesity
Hypertension
Molecules
Organs
Syndrome
Secretion
Therapeutics

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

@article{bca89793175145749a73268e8d1fed05,
title = "Adipokines as novel biomarkers and regulators of the metabolic syndrome.",
abstract = "Over the past two decades our view of adipose tissue has undergone a dramatic change from an inert energy storage tissue to an active endocrine organ. Adipose tissue communicates with other central and peripheral organs by synthesis and secretion of a host of molecules that we generally refer to as adipokines. The levels of some adipokines correlate with specific metabolic states and have the potential to impact directly upon the metabolic homeostasis of the system. A dysregulation of adipokines has been implicated in obesity, type 2 diabetes, hypertension, cardiovascular disease, and an ever-growing larger list of pathological changes in a number of organs. Here, we review the recent progress regarding the synthesis, secretion, and physiological function of adipokines with perspectives on future directions and potential therapeutic goals.",
author = "Yingfeng Deng and Scherer, {Philipp E.}",
year = "2010",
month = "11",
language = "English (US)",
volume = "1212",
journal = "Annals of the New York Academy of Sciences",
issn = "0077-8923",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Adipokines as novel biomarkers and regulators of the metabolic syndrome.

AU - Deng, Yingfeng

AU - Scherer, Philipp E.

PY - 2010/11

Y1 - 2010/11

N2 - Over the past two decades our view of adipose tissue has undergone a dramatic change from an inert energy storage tissue to an active endocrine organ. Adipose tissue communicates with other central and peripheral organs by synthesis and secretion of a host of molecules that we generally refer to as adipokines. The levels of some adipokines correlate with specific metabolic states and have the potential to impact directly upon the metabolic homeostasis of the system. A dysregulation of adipokines has been implicated in obesity, type 2 diabetes, hypertension, cardiovascular disease, and an ever-growing larger list of pathological changes in a number of organs. Here, we review the recent progress regarding the synthesis, secretion, and physiological function of adipokines with perspectives on future directions and potential therapeutic goals.

AB - Over the past two decades our view of adipose tissue has undergone a dramatic change from an inert energy storage tissue to an active endocrine organ. Adipose tissue communicates with other central and peripheral organs by synthesis and secretion of a host of molecules that we generally refer to as adipokines. The levels of some adipokines correlate with specific metabolic states and have the potential to impact directly upon the metabolic homeostasis of the system. A dysregulation of adipokines has been implicated in obesity, type 2 diabetes, hypertension, cardiovascular disease, and an ever-growing larger list of pathological changes in a number of organs. Here, we review the recent progress regarding the synthesis, secretion, and physiological function of adipokines with perspectives on future directions and potential therapeutic goals.

UR - http://www.scopus.com/inward/record.url?scp=79952259618&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952259618&partnerID=8YFLogxK

M3 - Article

C2 - 21276002

AN - SCOPUS:79952259618

VL - 1212

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

ER -